Latest | F'cast | |
---|---|---|
Div Yield | 3.0% | |
Div Cover | 1.5 | |
Op Mrgn | 28.0% | |
ROCE | 40.1% |
Latest | F'cast | |
---|---|---|
P/E | 22.9 | |
PEG | 7.3 | |
Pr/Revenue | 5.5 | |
Pr/Book | 24.7 |
Latest | F'cast | |
---|---|---|
Revenue | 7.1% | |
PBT | 6.9% | |
EPS | 3.1% | |
DPS | 8.7% |
Year Ending | Revenue ($m) | Pre-tax ($m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
---|---|---|---|---|---|---|---|---|
31-Dec-19 | 23,362.00 | 9,138.00 | 1,296.00¢ | 18.6 | 9.3 | +2% | 580.00¢ | 2.4% |
31-Dec-20 | 25,424.00 | 8,133.00 | 1,240.00¢ | 18.5 | n/a | -4% | 656.00¢ | 2.9% |
31-Dec-21 | 25,979.00 | 6,701.00 | 1,034.00¢ | 21.8 | n/a | -17% | 722.00¢ | 3.2% |
31-Dec-22 | 26,323.00 | 7,346.00 | 1,218.00¢ | 21.6 | 1.2 | +18% | 795.00¢ | 3.0% |
31-Dec-23 | 28,190.00 | 7,855.00 | 1,256.00¢ | 22.9 | 7.6 | +3% | 864.00¢ | 3.0% |
Year Ending | Revenue ($m) | Pre-tax ($m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
---|---|---|---|---|---|---|---|---|
31-Dec-24 | 33,167.55 | 14,792.83 | 1,958.32¢ | 14.7 | 0.3 | +56% | 909.02¢ | 0.0% |
31-Dec-25 | 34,292.59 | 15,497.98 | 2,064.39¢ | 13.9 | 2.6 | +5% | 976.84¢ | 0.0% |
31-Dec-26 | 34,878.77 | 15,475.22 | 2,125.08¢ | 13.5 | 4.6 | +3% | 1,035.40¢ | 0.0% |
Copyright © 2024 FactSet Research Systems Inc. All rights reserved.
SEP cashes in as US giant Amgen buys cancer drug... | 26-Jan-2011 | The Scotsman |
Amgen Buys a Cancer Drug Maker | 25-Jan-2011 | New York Times |
Tech Ticker | 16-Dec-2010 | BayArea.com |
Currency | US Dollars |
Share Price | $ 287.97 |
Change Today | $ 0.10 |
% Change | 0.03 % |
52 Week High | $339.19 |
52 Week Low | $262.75 |
Volume | 917,817 |
Shares Issued | 535.40m |
Market Cap | $154,179m |
RiskGrade | 100 |
Strong Buy | 6 |
Buy | 8 |
Neutral | 12 |
Sell | 2 |
Strong Sell | 1 |
Total | 29 |
Time | Volume / Share Price |
12:26 | 100 @ $287.97 |
12:26 | 100 @ $287.98 |
12:26 | 150 @ $287.96 |
12:26 | 300 @ $287.97 |
12:26 | 118 @ $288.04 |
You are here: research